141 related articles for article (PubMed ID: 10074901)
21. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
22. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
[TBL] [Abstract][Full Text] [Related]
23. Expression of Gab1 lacking the pleckstrin homology domain is associated with neoplastic progression.
Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Abe T; Takeuchi T; Glasgow WC; Eling TE
Mol Cell Biol; 2001 Oct; 21(20):6895-905. PubMed ID: 11564873
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
25. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
27. Differential tumorigenicity of growth factor-dependent versus -independent CCL39 lung fibroblast lines in nude mice.
Renwick DE; Franchi AJ; Pouysségur JM; Lagarde AE
J Natl Cancer Inst; 1986 Jul; 77(1):105-14. PubMed ID: 3459908
[TBL] [Abstract][Full Text] [Related]
28. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
29. Emergence of hamster fibroblast tumors in nude mice--evidence for in vivo selection leading to loss of growth factor requirement.
Pérez-Rodriguez R; Chambard JC; Van Obberghen-Schilling E; Franchi A; Pouysségur J
J Cell Physiol; 1981 Dec; 109(3):387-96. PubMed ID: 7320057
[TBL] [Abstract][Full Text] [Related]
30. VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.
Ke LD; Shi YX; Yung WK
Cancer Res; 2002 Mar; 62(6):1854-61. PubMed ID: 11912165
[TBL] [Abstract][Full Text] [Related]
31. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
32. Fas expression inversely correlates with metastatic potential in osteosarcoma cells.
Worth LL; Lafleur EA; Jia SF; Kleinerman ES
Oncol Rep; 2002; 9(4):823-7. PubMed ID: 12066216
[TBL] [Abstract][Full Text] [Related]
33. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.
Rong S; Donehower LA; Hansen MF; Strong L; Tainsky M; Jeffers M; Resau JH; Hudson E; Tsarfaty I; Vande Woude GF
Cancer Res; 1995 May; 55(9):1963-70. PubMed ID: 7728766
[TBL] [Abstract][Full Text] [Related]
34. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes.
Sharif A; Prévot V; Renault-Mihara F; Allet C; Studler JM; Canton B; Chneiweiss H; Junier MP
Oncogene; 2006 Jul; 25(29):4076-85. PubMed ID: 16532035
[TBL] [Abstract][Full Text] [Related]
36. Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors.
Mayer SI; Rössler OG; Endo T; Charnay P; Thiel G
J Cell Sci; 2009 Sep; 122(Pt 18):3340-50. PubMed ID: 19706684
[TBL] [Abstract][Full Text] [Related]
37. Dose-dependent transformation of cells of human fibroblast cell strain MSU-1.1 by cobalt-60 gamma radiation and characterization of the transformed cells.
O'Reilly S; Walicka M; Kohler SK; Dunstan R; Maher VM; McCormick JJ
Radiat Res; 1998 Nov; 150(5):577-84. PubMed ID: 9806600
[TBL] [Abstract][Full Text] [Related]
38. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.
Sousa Vde O; Romão L; Neto VM; Gomes FC
Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546
[TBL] [Abstract][Full Text] [Related]
39. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
40. Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells.
Morrison RS; Giordano S; Yamaguchi F; Hendrickson S; Berger MS; Palczewski K
J Neurosci Res; 1993 Apr; 34(5):502-9. PubMed ID: 8478985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
